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Running title: Insulin and diacylglycerol kinase activity in synaptic 
terminals.
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Abstract 
The highly efficient formation of phosphatidic acid from exogenous 1-stearoyl-
2-arachidonoyl-sn-glycerol (SAG) in rat brain synaptic nerve endings 
(synaptosomes) from cerebral cortex and hippocampus is reported.
Phosphatidic acid synthesized from SAG or 1,2-dipalmitoyl-sn-glycerol (DPG) 
was 17.5 or 2.5 times higher, respectively, than from endogenous 
synaptosomal diacylglycerides. Insulin increased diacylglycerol kinase (DAGK) 
action on endogenous substrate in synaptic terminals from hippocampus and 
cerebral cortex by 199% and 97% respectively. Insulin preferentially increased 
SAG phosphorylation from hippocampal membranes. In CC synaptosomes
insulin increased phosphatidic acid (PA) synthesis from SAG by 100% with 
respect to controls. Genistein (a tyrosine kinase inhibitor) inhibited this 
stimulatory insulin effect. Okadaic acid or cyclosporine, used as Ser/Threo 
protein phosphatase inhibitors, failed to increase insulin effect on PA 
formation. GTPS and particularly NaF were potent stimulators of PA formation 
from polyunsaturated diacylglycerol but failed to increase this phosphorylation 
when added after 5 min of insulin exposure. GTPS and NaF increased 
phosphatidylinositol 4,5 bisphosphate (PIP2) labeling with respect to controls 
when SAG was present. On the contrary, they decreased polyphosphoinositide 
labeling with respect to controls in the presence of DPG. Our results indicate 
that a DAGK type 4 (DAGK) which preferentially, but not selectively, utilizes 1-
acyl-2-arachidonoyl-sn-glycerol and which could be associated with 
polyphosphoinositide resynthesis, participates in synaptic insulin signaling. 
GTPS and NaF appear to be G protein activators related to insulin and the 
insulin receptor, both affecting the signaling mechanism that augments 
phosphatidic acid formation.
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Introduction
Brain insulin receptors (IRs) are present in particularly high 
concentrations in neurons and abundant IRs are found in cell bodies and 
synapses (1). Several studies have drawn links between insulin signaling and 
intracellular trafficking and plasma membrane expression of ion channels and 
neurotransmitter receptors at the central nervous system,  mainly cerebral 
cortex (CC) and hippocampus (Hp) synapses (2; 3).. 
It is known that growth factor transduction acts partly by PA generation 
through phospholipase D (PLD) activation. We previously explored insulin 
action on different enzymes in relation to PA and DAG generation. It has 
recently been reported that after insulin action, PA formation is stimulated in 
CC synaptosomes from adult rats (4) and that PLD and diacylglycerol kinase 
(DAGK) activities were strongly stimulated by insulin. Phospholipase inhibitors 
were then used to identify the role of two phospholipases in DAGK activation 
by insulin. Our results indicate that DAGK acts in response to increased DAG 
generated by PIP2-PLC and PLD-PAP2 pathways (5), this action being 
reinforced by an additional DAGK activation mechanism exerted by the 
hormone. Insulin induces significant DAGK stimulation in the presence of 
exogenous [3H] DAG, which exhibits a complex fatty acid composition. Our 
results also show that in CC synaptosomes, insulin preferentially stimulates PA 
formation through SAG as exogenous substrate (5). 
The arachidonate-enriched DAG pool that arises during stimulus-induced 
PI turnover is rapidly phosphorylated by a DAGK, much of this PA ultimately 
converting back into PI (4; 6; 7). Other DAG species are phosphorylated much 
more slowly. Since of the ten DAGK isoforms only DAGK shows substrate 
selectivity (8) and other DAG kinases show no fatty acyl selectivity, it is likely 
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that arachidonoyl-DAG kinase is the isoform responsible for this DAG 
phosphorylation. Regulation of arachidonoyl-DAG kinase by PIP2 feedback has 
been demonstrated in vitro showing PIP2 to be a potent and specific inhibitor 
of this isoform (9). The stimulation of other DAG kinases by PIP2 and PA, while 
raising the possibility that these enzymes may be activated by PA or 
polyphosphoinositides (PPI), does not support their role in regulating the level 
of PIP2. Given the marked enrichment of animal cell phosphatidylinositols in 
arachidonate at the glycerol sn-2 position, the substrate selectivity of 
arachidonoyl-DAG kinase is indicative of a special role of DAGK in PI 
resynthesis.
Here we carried out studies on CC synaptic endings to evaluate potential 
regulators of insulin action on PA synthesis from exogenous saturated (DPG) 
and unsaturated (SAG) diacylglycerol. Our experimental model represented 
conditions where DAG from PC-PLD or from PIP2-PLC is present. Insulin 
action on PA formation could therefore be studied independently of its action 
on DAG production. Insulin action on DAGK activity in synaptic endings from 
rat Hp was also explored. 
To characterize insulin action on CC synaptosomal DAGK, we analyzed 
PA formation in the presence of either Ser/Thr and Tyr protein phosphatase 
inhibitors or a Tyr kinase inhibitor. Type I DAGK isoforms (,  and ) are 
mainly present in CNS, R59022 and R59949, being potent inhibitors of these 
calcium dependent isoforms (10). To evaluate the possible involvement of type 
I DAGK action on exogenous DAG, we used these inhibitors in assays with 
endogenous or exogenous lipid substrate. Since PIP2 is a potent inhibitor of 
DAGK, GTPS was used as G protein activator to increase PIP2 hydrolysis. 
NaF was also evaluated as a potential regulator of insulin action on DAGK 
activity.  
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Our results suggest that DAGK could participate in insulin signaling in 
CC synaptosomes and that activation of this enzyme is mediated through the 
regulation of PIP2 levels. NaF and GTPS appear to be G protein activators 
that activate PA formation in IR-related transduction pathways.
Experimental Procedures
Materials
Four-month-old (adult) Wistar-strain rats were used. Animals were kept 
under constant environmental conditions and fed on a standard pellet diet. 
They were killed by decapitation and cerebral cortices and hippocampus were 
immediately dissected from rat brain hemispheres (2-4 min after decapitation). 
Synaptosomal fraction was obtained following Cotman (1974) with slight 
modifications (11). [-32P]ATP (3,000 Ci/mmol) and Omnifluor were obtained 
from New England Nuclear-Dupont (Boston, MA). All the other chemicals were 
from Sigma Aldrich (St. Luis, MO).
Determination of DAGK activity
DAGK activity was determined in purified synaptosomal membranes 
measuring radioactive phosphate incorporation into PA using [-32P] ATP and 
a) endogenous DAG as substrate or b) different concentrations of DPG or SAG 
(specified in the text figures) as exogenous substrates. The standard assay 
contained 0.1 % DMSO or 50 mM octyl--glucopyranoside (OG), 50 mM Hepes, 
pH 7.4, 10 mM MgCl2, 1 mM DTT and 0.5 mM ATP in a volume of 200 l. 
When exogenous DAG was added to the assay, an appropriate volume of DAG 
stock solution was evaporated under a stream of nitrogen in a glass test tube. 
It was then re-suspended in DMSO or in OG and the detergent-lipid mixture 
was sonicated in a test tube into a Cup Horn system (Branson Digital Sonifier, 
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model 450). Prior to incubation, synaptosomes were also sonicated during 15 
sec with radioactive ATP and detergent-lipid suspension in a water bath 
(Branson Sonifier). Reactions were performed at 37 ºC during 5 min. Integrity 
of incubated synaptosomes in 0.1 % DMSO (endogenous DAG condition) or 
with DMSO-DPG or DMSO-SAG conditions was controlled by fluorescence 
mycroscopy with Nile Red stain. 
Blanks were prepared identically, except that membrane fractions were 
boiled for 5 min before use. 
For a standard assay, when [-32P] ATP was used as radioactive 
substrate, reactions were stopped by adding chloroform/methanol/1N HCl 
(2:1:0.2, by volume) and lipids were extracted following Folch et al. (1957). 
Five additional washes of the lipid extract for [-32P] ATP elimination were 
carried out using theoretical upper phase. PA, PIP and PIP2 were separated by 
TLC on 1% potassium oxalate in silica gel H developed with 
chloroform/acetone/methanol/acetic acid/water (40:15:13:12:7.5, by vol) (12). 
Lipids were visualized by exposure of the chromatograms to iodine vapors and 
scraped off for counting by liquid scintillation spectroscopy. Protein was 
determined according to Bradford’s method (1976).
Statistical analysis
All data are given as means  SD. Statistical analysis was evaluated by the 
Student´s t-test or one-way analysis of variance (ANOVA) followed by Tukey´s 
post hoc test. Statistical significance was set at P<0.05. 
Results
Exogenous SAG was preferentially used for PA synthesis in CC 
synaptosomes 
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To evaluate PA formation in synaptosomes from CC, exogenous DAG, 
DPG and SAG were presented in a micellar assay with 50 mM OG. PA 
formation from SAG was 17 times higher than with endogenous DAG under this 
condition, and PA formation from DPG 2.4 times higher than with endogenous 
DAG (Table I). As previously reported the OG assay appears to be ideal for 
evaluating DAGK action on SAG (6). The preferential SAG over DPG utilization 
was also observed in the DMSO assay (Table I). It is interesting to note that 
PIP and PIP2 labeling was negligible under OG condition (data not shown). 
The preferential transformation with 250 M SAG also occurs when the 
enzyme action on DPG is at saturating concentration. In order to study kinetic 
properties we compared synaptosomal DAGK action on exogenous DAG using 
different ATP and DAG concentrations. PA labeling with DPG as substrate 
increased as a function of increasing ATP concentrations, reaching saturation 
at 2 mol% DAG and 4 mM ATP. PA formation from SAG reached saturation at 
4 mol% SAG and 4 mM ATP (data not shown). Since our experiments were 
carried out at 0.5 mol% DAG and 0.5 mM ATP, the saturating concentrations 
for DPG and ATP are not a factor to be taken into account. The results of the 
OG micellar assay indicate that exogenous SAG was preferentially used for PA 
synthesis in CC synaptosomes.
SAG is not a positive regulator for non-acyl selective DAG kinases 
It was initially believed that preferential utilization of SAG for PA formation 
was only apparent and that unsaturated DAG could act as a positive regulator 
for non-selective DAGK isoforms. To explore this possibility, synthesis of PA 
from 10 M SAG was measured in the absence and presence of 250 M DPG. 
Controls were carried out with 10 M and 250 M DPG only. As shown in 
Figure 1, PA formation with 250 M DPG was three times higher than with 10 
M DPG (160 and 40 pmole/mg prot x 5 min respectively). Interestingly, in the 
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presence of only 10 M SAG, PA formation was 190 pmole/mg prot x 5 min PA 
formation when 10 M SAG was added to 250 M DPG was only additively 
increased (376 pmole/mg prot x 5 min).  These results suggest that: 1) SAG 
seems not to be a positive regulator for non-acyl selective DAG kinases; and 2) 
under the present assay conditions only enzymatic activity from one isoform 
(DAGK) was detected as having different kinetic parameters for saturated and 
unsaturated DAG or, alternatively, different isoform activities were detected, 
among them DAGK.
Neither R59022 nor R59949 inhibited PA synthesized from DPG or SAG
R59949 and R59022 (10) inhibit DAG phosphorylation by erythrocyte 
ghosts and platelet membranes, and also inhibit some DAGK isozymes. It was 
recently reported that R59949 action on DAGK isoforms is selective, all 
calcium-activated DAGK members being sensitive to this agent whereas Ca++-
insensitive isoforms were only slightly affected. A marked reinforcement of 
R59949 DAGK inhibition by MgATP (up to 0.2 mM) was also reported. Neither 
R59022 nor R59949 inhibited arachidonoyl-DAG-specific DAGK from testis 
(10). 
Assays with 250 M DPG or SAG in the presence of 10 M of R59022 (at 
0.5 mM ATP) and 0.24 M of R59949 (at 4 mM ATP) were carried out. As 
previously shown, preferential unsaturated DAG utilization was optimal in OG 
assays (Table I). Since it has been reported that R59022 and R59949 are 
poorly soluble in OG, which is commonly used to disperse the DAG substrate 
(10), a DMSO assay was performed. Neither R59022 nor R59949 (at 0.5 or 4 
mM ATP respectively) inhibited PA synthesized from DPG or SAG in the 
absence of Ca++ (Fig. 2, upper panel, white bars).  A similar result was 
obtained when Ca++ was included with exogenous DAG in the assay (Fig. 2, 
lower panel). However, R59022 is shown to inhibit DAGK activity using 
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endogenous DAG as lipid substrate in the presence of Ca++. It has been 
reported that in particulate fractions of vascular tissue, using micelar SAG in 
73 mM OG (13), R59022 has inhibitory effects on DAGK, even at 3 µM, thus 
indicating that this inhibitory concentration is sufficient when the enzyme is 
sensitive.
The preferential use of SAG over DPG for PA synthesis could be due to 
the different kinetic parameters of DAGK activity for saturated and unsaturated 
DAG substrates detected in our assay. Summing up, this enzyme activity 1) is 
activated by OG; 2) is insensitive to R59022 and R59949 in the absence of 
calcium and 3) is insensitive to R59022 in the presence of calcium.
Insulin stimulated DAGK activity through a tyrosine kinase-dependent 
mechanism   
As showed in Fig 2, upper panel, (controls) insulin increased PA formation 
from DPG and SAG to the same extent. Inhibitors were not able to modify this 
increased PA labeling in the presence of insulin. 
Different potential regulators were assessed in order to find out how 
insulin affects DAGK action on SAG. The tyrosine kinase activity of the insulin 
receptor appears to be essential for certain cellular responses to insulin.  The 
tyrosine phosphotransferase function of the insulin receptor is an absolute 
requirement for the hormone to activate the receptor signaling function in cells. 
Genistein, a tyrosine kinase inhibitor and vanadate, a tyrosine phosphatase 
inhibitor, were then used to indirectly assess IR mediation in DAGK activation. 
It is interesting to note that DAGK assays, as with other phosphorylation 
assays, usually contain 10–20 mM NaF as protein phosphatase inhibitor. 
However, it was reported that solubilized insulin receptor and IGF-I receptor 
preparations in the presence of NaF caused an almost total inhibition of 
receptor autophosphorylation and tyrosine kinase activity toward exogenous 
substrates (14). It was also observed that the inhibitory effect of fluoride on 
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phosphotransferase activity was not due to the formation of aluminum 
complexes and was dependent on the Mg2+ concentration in the medium (15). 
Experimental conditions were then modified to evaluate insulin action on PA 
formation in the absence and presence of NaF.
As shown in Figure 3, insulin in the presence of vanadate (I+V) gave rise 
to a one-fold increase in DAGK action on SAG. When genistein plus insulin 
were present, PA synthesis was the same as in the controls. NaF plus I+V 
stimulated a one-fold increase in PA formation with respect to I+V alone.
Figure 4 shows comparative data from SAG and DPG phosphorylation in 
the absence and presence of insulin. Data were calculated as percentages of 
DAGK activity on endogenous DAG in the basal condition.  PA formation from 
SAG is higher than from DPG, even in the presence of insulin. As a 
consequence of the high preferential utilization of SAG, PA formation 
increased nine fold with respect to endogenous values in the presence of 
insulin. Figure 4 (insert), where data are expressed as percentage with respect 
to incorporation values of insulin condition, shows how NaF reinforces (0.5 
fold) insulin’s stimulatory effect on PA formation from saturated and 
unsaturated DAG to a similar degree. However, in the presence of insulin + 
NaF, PA formation from SAG is 16 times higher than from endogenous DAG
and PA formation from DPG is only 8 times higher.
The stimulatory effect of NaF on PA synthesis is not related to Ser/Thr 
protein phosphorylation protection
As mentioned, NaF is a classical Ser/Thr protein phosphatase inhibitor 
(16) and is routinely included in extraction buffers to prevent dephosphorylation 
of proteins on Ser and Thr residues by endogenous phosphatases. We 
therefore examined the effect of different inhibitors of Ser/Thr protein 
phosphatase activities on PA synthesis using 250 M SAG and DPG as 
substrate (Figure 5). Okadaic acid (a PP1 and PP2A inhibitor) and cyclosporin 
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A (PP2B inhibitor) were assessed at low (0.5 mM) ATP concentration. The 
control contained no NaF or vanadate in the medium. Since the phosphatase 
inhibitory effect of these drugs is not evident at high ATP concentration, an 
additional assay (4 mM ATP) was carried out. 
The presence of okadaic acid and particularly cyclosporin A in the pre-
incubation of synaptosomal membranes at low ATP concentration inhibited 
insulin-stimulated PA synthesis from DPG and SAG. As expected, these 
actions were not observed at high ATP concentration. However, NaF strongly 
increased PA synthesis at low (Figure 5a) and high (Figure 5b) ATP 
concentrations. It can therefore be hypothesized that the stimulatory effect of 
NaF on PA synthesis is not related to Ser/Thr protein phosphorylation 
protection. 
It is well known that the phosphorylation of inositol phospholipids 
phosphorylated in the 3 hydroxyl position by phosphatidylinositol 3 kinase 
(PI3K) is stimulated by insulin in a broad spectrum of insulin-responsive 
tissues (17). We speculate that NaF is also involved in a selective protein 
phosphatase acting on Akt Ser/Thr that could be phosphorylated by this 
transduction mechanism upstream of DAGK activation. However, in the 
presence of LY294002, a selective PI3K inhibitor, insulin stimulation of PA 
synthesized from DPG or SAG was unchanged (data not shown).
NaF and GTPS activate PA synthesis from exogenous DPG or SAG
Many of the cellular activities of NaF are attributed to a fluoride complex 
with aluminium, forming fluoraluminates that activate heterotrimeric G proteins 
(18). In order to explore G protein participation in DAGK activity stimulated by 
insulin, pre-incubation with GTPS, a full G protein activator (19) was 
evaluated. NaF and GTPS activity was assessed as a function of time in the 
absence and the presence of the hormone. As shown in (Figure 6, left panels), 
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at 5 min incubation without the hormone, NaF and GTPS activate PA 
synthesis from exogenous DPG, representing 306 % and 140 % of control 
values, respectively. When SAG is the substrate, NaF and GTPS give rise to a 
similar increase in PA formation. However, when NaF and GTPS are added 
after 5 min exposure to insulin along 5 min incubation time they fail to enhance
PA synthesis (Figure 6, right panels).
PIP2 labeling was inhibited by GTPS or NaF in the presence of 
exogenous DPG
G protein activation by GTPS actively increases PPI labeling through 
PIP2 hydrolysis activation and its subsequent resynthesis. In Figure 6 and 
Figure 7, it can be seen that in the presence of exogenous DPG, GTPS and 
NaF increase PA labeling but decrease PIP2 labeling with respect to the 
controls (Figure 7, left panel). GTPS and NaF also serve to increase PA 
labeling in the presence of SAG, but in this case PIP2 labeling remains the 
same or increases instead of decreasing (Figure 7, right panel). These data 
are in agreement with the hypothesized close relationship between 18:0-20:4 
PA formation and PPI phosphorylation (5).
Taking into account that PIP2 is a potent inhibitor of DAGK we speculate 
that regulation of PIP2 levels through phospholipases C activation could be 
involved in the stimulation of PA formation. 
3.9. NaF inhibited insulin action on polyphosphoinositides 
phosphorylation   
Figure 8 shows the effect of insulin on PA and PIP plus PIP2 labeling in 
the absence and presence of NaF, with a sharp increase in PA formation when 
SAG is the substrate (77 % with respect to the control). The same effect was 
observed in the DPG assay with a 72 % PA synthesis compared to controls. 
This Figure also shows that NaF significantly increases PA formation with 
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respect to the insulin condition (52 % and 95 % in the presence of SAG or 
DPG, respectively).  Insulin strongly increases PIP plus PIP2 labeling. 
However, when NaF is added to insulin, a strong inhibition of PIP plus PIP2
labeling was observed, showing values 80% lower with both DAG than in the 
insulin condition.
3.10. Insulin preferentially increased SAG phosphorylation from Hp 
membranes 
Comparative experiments with Hp synaptosomal preparations were also 
carried out and revealed that PA synthesized from SAG or DPG is 18.16 or 
3.58 times higher than from endogenous DAG, respectively (Table II). Insulin
strongly increased DAGK action on endogenous DAG in synaptic terminals 
from Hp (199 % with respect to control). Insulin preferentially increased 
polyunsaturated PA synthesis from Hp membranes (175 % in Hp membranes 
and 65 % in CC membranes).
4. Discussion 
PA formation is stimulated by insulin in CC synaptosomes from adult rats 
(5). Our previous results indicated that DAGK acts partly in response to 
increased DAG generated by insulin-activated PIP2-PLC and PLD-PAP2 
pathways.  This action is reinforced by an additional insulin-induced DAGK 
activation mechanism apparently related to polyunsaturated DAG 
phosphorylation. This effect was also observed when exogenous radioactive 
DAG ([3H]-DAG) of complex composition was used as substrate for DAGK 
determination (4). 
In the present study it was demonstrated that membrane preparations 
from CC synaptic terminals preferentially synthesize PA from SAG rather than 
DPG. Although the use of polyunsaturated DAG was higher in the OG assay 
than in the DMSO assay, the preferential synthesis of polyunsaturated PA was 
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similar in the two cases. This observed preference for SAG was independent of 
the DPG (250 M) or ATP (0.5 mM) concentration, since these values are not 
saturating substrate / co-substrate concentrations, respectively (data not 
shown). The possibility that unsaturated DAG acts as a positive regulator of a 
non acyl-selective DAGK was also discarded (Figure 1). Interestingly, PA 
synthesis from SAG was also found to be predominant in synaptosomes from 
Hp (Table II).  
Ten mammalian DAGK isozymes have been identified to date, including 
the recently cloned DAGK (20). One of the important features of the DAGK 
family is that most of the isozymes, except for class II, are highly expressed in 
the brain, indicating their physiological importance in the central nervous 
system. DAGK is unique among the DAG kinases in that it preferentially 
phosphorylates DAG with an arachidonate— an unsaturated fatty acid—in the 
sn2 position. This selectivity suggests that DAGK has a more prominent role 
than other DAGK isoforms in enriching a precursor pool for inositol 
phospholipid synthesis with unsaturated fatty acids (8).
Interestingly, DAGK-deficient mice had significantly shorter seizures 
following electroconvulsive shock and they also recovered faster than wild-type 
mice (21). In this DAGK-deficient experimental model, examination of brain 
lipids revealed reduced levels of arachidonate in both PIP2 and DAG. Like 
human DAGK, the murine counterpart expressed in COS cells displayed high 
selectivity for 20:4-DAG as compared with oleoyl-DAG (10-fold higher) (21). 
The present study reports evidence of synaptosomal PA formation in a 
DAGK assay showing detergent (OG) and substrate (SAG) preference as well 
as insensitivity to R59022 and R59949 (DAGK inhibitors) in the absence and 
presence of calcium ions. All these data indirectly indicate the preferential 
formation of PA through a DAGK activity under our assay conditions. 
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Our data also reveal that in a tyrosine phosphorylation-dependent 
mechanism, the level of the insulin-induced increase in PA synthesis is the 
same whether saturated or unsaturated exogenous DAG is used as substrate. 
As a consequence of the high preferential SAG utilization, unsaturated PA 
formation from CC synaptic terminals in the presence of insulin was 
significantly higher than saturated PA. On the other hand, insulin effect on PA 
formation occurs preferentially in SAG in Hp membranes, rather than CC.
The stimulatory effect on PA formation was reinforced by the 
simultaneous presence of insulin and NaF. Although NaF is a Ser/Thr 
phosphatase inhibitor (16) the mediation of PP1, PP2A or PP2B in the insulin-
dependent activation was discarded by using the selective protein phosphatase 
inhibitors okadaic acid and cyclosporin A. 
NaF is also a potent, rapid, and reversible activator of the regulatory 
heterotrimeric GTP-binding protein in virtually all in vitro systems. It has been 
reported that the effect of NaF on these G proteins is the result of the 
formation of AlF4 from fluoride and trace amounts of aluminum, which can 
come from contaminated glassware (22).
One can speculate that the NaF effect is mediated by a G protein-
dependent activation of PIP2-PLC. Although the increase in saturated and 
unsaturated PA formation was similar with respect to the control level, PIP2 
phosphorylation decreased sharply (DPG, Fig. 7, right panel) or increased 
slightly (SAG, Fig. 7, left panel). It can therefore be hypothesized that PIP2 
hydrolysis occurs and a PIP2 resynthesis mechanism takes place as 18:0-20:4 
PA increases.  
Upon evaluation of phosphoinositide phosphorylation (PIP plus PIP2) 
under the usual ATP phosphorylation assay condition of DAGK, labeling 
increased in the presence of insulin. However, PIP+PIP2 phosphorylation 
decreased in the presence of NaF with respect to values obtained with the 
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hormone (Figure 8). Taking into account that PIP and particularly PIP2 are 
potent inhibitors of DAGK (9), NaF reinforcement of DAGK insulin-stimulation 
could be due to a dual fluoride action that negatively regulates PPIs levels as 
previously described in brain slices exposed to carbachol and GTPS (23; 24). 
These authors reported strong PIP2 depletion as a consequence of 
phospholipase C activation, and the inhibition of PPI synthesis. 
It can be surmised that in the presence of insulin, NaF causes maximal 
depletion of PPIs level. A G protein-dependent activation of PIP2-PLC (AlF4 as 
activator) together with a diminution of PPIs availability through 
phosphatidylinositol kinase inhibition may occur.
The co-activation mechanism by G protein activators (such as GTPS or 
NaF) could conceivably have been experimentally started in the absence of IR 
activation, but in this case it would most likely take place on a molecular target 
implicated in IR signaling (such as a G protein-related target).
It is known that the  subunits (q, 11, 14, and 16) of all four 
members of the Gq subfamily of heterotrimeric G proteins activate PLC-
isozymes but not PLC-1 or PLC-1 (25). Polypeptide growth factors such as 
platelet-derived (PDGF), epidermal, fibroblast, nerve and hepatocyte growth 
factors all induce PIP2 turnover by activating PLC- in a wide variety of cells. 
Binding of these growth factors to their receptors results in the activation of 
intrinsic protein tyrosine kinase receptor activity and the consequent tyrosine 
phosphorylation of numerous proteins, including the receptor itself and PLC-
(26). Thus, PLC- appears to be a good candidate to explain PIP2-PLC 
activation by insulin (5). 
Our present results also lead us to suggest that increased PIP2 
hydrolysis selectively stimulate the DAGK isoform. This isoform could be 
negatively regulated when high PIP2 levels occur. How do we explain GTPS 
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or NaF activation of this regulatory mechanism? We postulate an IR-related co-
activation mechanism inducing stimulation of PIP2 resynthesis. 
Using insulin receptors isolated from plasma membranes of human fat 
cells, it has recently been demonstrated that the activation of the insulin 
receptor autophosphorylation by insulin is sensitive to activators (e.g. GTPS) 
as well as to inhibitors (e.g. GDPβS and pertussis toxin) of G-protein function 
(27). These authors also report that activation of G-proteins by GTPS induces 
a 5-fold increase in receptor autophosphorylation over baseline values and a 3-
fold increase in insulin-induced autophosphorylation. 
Conversely it was reported that protein tyrosine phosphatases (PTPs) are 
essential for Gq/11 protein activation (28), which together with previous 
observations suggests that tyrosine kinases and PTPs co-operate to activate 
the Gq/11 protein by regulating tyrosine phosphorylation of the Gq/11 subunit 
(28; 29). 
How the insul in-re lated DAGK act ivat ion mechanism in CC 
synaptosomes is regulated by G protein efectors st i l l  remains to be 
elucidated. 
It is known that phosphatidylinositols are enriched at the sn2 position with
arachidonate. As previously mentioned, most DAGK isoforms do not distinguish 
between the fatty acid components of DAG in vitro, thus suggesting that in vivo
phosphatidylinositols maintain their unsaturated fatty acid enrichment by 
coupling PI-specific phospholipase C enzymes with DAG kinases and other 
enzymes involved in resynthesizing PIP2. Coupling these enzymes could 
maintain the fatty acid components of PIP2  (30; 31). 
DAGK predominantly phosphorylates DAG with an arachidonate in the 
sn2 position (6),  supporting the notion that DAGK plays a more prominent 
role than other DAGK isoforms in enriching brain inositol phospholipids with 
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unsaturated fatty acids (8; 21). Although DAGKε is able to phosphorylate DPG 
or other saturated DAGs, it is highly efficient in the 2-arachidonoyl DAGs 
phosphorylation (32). It could therefore be suggested that 2-arachidonoyl PA is 
involved in the synthesis of phosphatidylinositol and the replenishment of the 
precursor by phosphorylations to PIP and PIP2 or as a phosphoinositide kinase 
regulator. Further studies will be necessary to explain this in the context of 
neural insulin signaling. 
Insulin and its receptor are widely localized throughout the brain though 
most densely found in the olfactory bulb, cerebral cortex, hypothalamus, and 
hippocampus. They are related to various functions including regulation of 
glucose metabolism, food intake and body weight, learning, memory, and 
attention (3; 33; 34). At the synapse, insulin receptors regulate 
neurotransmitter release and receptor recruitment, indicating a potential 
involvement of insulin in synaptic plasticity (1). However, the molecular 
mechanism by which insulin exerts these beneficial effects has not been 
elucidated to date. 
The present results suggest that DAGKε activity is stimulated by insulin in 
synaptic terminals from Hp and CC and that insulin preferentially stimulates PA 
formation from SAG in Hp synaptosomes. The stimulation of IR-related PIP2 
hydrolysis as we previously reported (5) could remove PIP2 as a DAGKε-
negative regulator.  Insulin-induced DAGKε activity could participate in a final 
PIP2 resynthesis mechanism as a consequence of G protein-mediated PIP2-
PLC activation. In conclusion, activation of DAGKε and arachidonate-rich PA 
formation may potentially be involved in inositol lipid homeostasis at the 
synapse, opening an interesting avenue for brain insulin signaling studies.
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Fig. 1: Is SAG a positive regulator of DPG phosphorylation? 
DAGK activity was determined in synaptosomal membranes incubated during 5 
min in the assay condition as described under “Experimental Procedures” by 
measuring radioactive phosphate incorporation into PA through [-32P]ATP as 
radioactive substrate. The lipid substrate was 250 M 1,2-dipalmitoyl-sn-
glycerol (DPG) either alone or in combination with 10 M 1-stearoyl-2-
arachidonoyl-sn-glycerol (SAG) in a detergent-micellar assay (OG as 
detergent). Controls have 10 M DPG or SAG.  Lipids were resuspended in 
dimethylsulfoxide (at a final concentration of 0.1 %). Results are expressed as 
the mean  S.D. of the incorporation values obtained in three individual 
samples.
***P < 0.0001 vs. DPG 10 µM, ###P < 0.0010 vs. DPG 250 µM.
Fig. 2: DAGK activity with SAG or DPG in the presence of insulin. R59022 
and R59949 effects. 
Upper panel: DAGK activity was determined in CC synaptosomal membranes 
incubated during 5 min in the assay condition as described under 
“Experimental Procedures” by measuring radioactive phosphate incorporation 
into PA through [-32P]ATP as radioactive substrate in the presence of 250 µM 
SAG or DPG in the absence or presence of 200 nM insulin. Five minutes of 
incubation was carried out after ten minutes of pre-incubation in the absence 
or in the presence of either 10 µM R59022 or 0.24 µM R59949. In all insulin 
conditions 200 M vanadate was present. The lipid was resuspended in DMSO 
at a final concentration of 0.1% in the assay condition without exogenous 
calcium ions. Lower panel: DAGK activity was determined in CC synaptosomal 
membranes incubated during 5 min in the assay condition described under 
“Experimental Procedures”, modified by the presence of 0.1 mM calcium ions,
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by measuring radioactive phosphate incorporation into PA through [-32P]ATP 
as radioactive substrate in the presence of endogenous DAG or with either 250 
µM SAG or DPG (DMSO as detergent). Incubation for five minutes after ten 
minutes of pre-incubation in the absence or presence of 10 µM R59022 was 
carried out. Lipids were resuspended in DMSO (at a final concentration of 0.1 
%). Results are calculated as percentages of incorporation values. Controls 
are set at 100 and the values are means ± S.D. of six individual samples. In 
upper panel, the significance degrees were calculated vis-à-vis their respective 
controls (basal or insulin) without R59022 and R59949. In the lower panel, the
significance levels were calculated vis-à-vis their respective controls without 
R59022.
*P < 0.050, ***P < 0.0010.
Fig. 3: Insulin effect on synaptosomal DAGK action on exogenous SAG 
measured with either genistein or vanadate. Effect of sodium fluoride.
DAGK activity was determined in CC synaptosomal membranes incubated 
during 5 min in the assay condition as described under “Experimental 
Procedures” by measuring radioactive phosphate incorporation into PA through 
[-32P]ATP as radioactive substrate in the presence of 250 µM SAG (DMSO as 
detergent). The incubation time was started with insulin addition after ten min 
pre-incubation in the presence of inhibitors. Results are calculated as 
percentages of incorporation values. Controls are set at 100 and the values are 
means ± S.D. of six individual samples. Significance levels were calculated vis-
à-vis the controls. 
***P < 0.0001 vs. control, #P < 0.050 vs. insulin condition.
Fig. 4: Effect of insulin on synaptosomal DAGK action on DPG and SAG. 
Sodium fluoride action. 
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DAGK activity was determined in CC synaptosomal membranes incubated 
during 5 min in the assay condition as described under “Experimental 
Procedures” by measuring radioactive phosphate incorporation into PA through 
[-32P]ATP as radioactive substrate in the absence (endogenous DAG) or in 
the presence of either 250 µM DPG or SAG (DMSO as detergent). The 
incubation time was started with insulin (200 nM) addition after ten min pre-
incubation in the presence of vanadate (200 M) (black bars, insulin condition)
or insulin plus NaF (insert, stacked gray bars). Results are calculated as 
percentages of incorporation values. Control (endogenous DAG as lipid 
substrate) is set at 100 and the values are the mean ± S.D. of six individual 
samples. Significance levels were calculated vis-à-vis the control condition. 
Insert: NaF action on synaptosomal DAGK activity in the presence of insulin 
(DPG or SAG as substrates) is calculated as a percentage of mean 
incorporation values from insulin condition (set at 100). The significance levels 
of insulin conditions were calculated vis-à-vis the respective basal condition.
The significance levels of insulin+NaF conditions were calculated vis-à-vis the 
respective insulin condition.
**P < 0.005 vs. basal, ###P < 0.0001 vs. insulin condition.  
Fig. 5: Effect of insulin on synaptosomal DAGK action on DPG and SAG. 
Action of Ser/Thr protein phosphatase inhibitors. 
DAGK activity was determined in CC synaptosomal membranes incubated 
during 5 min in the assay condition as described under “Experimental 
Procedures” by measuring radioactive phosphate incorporation into PA through 
[-32P]ATP as radioactive substrate in the presence of either 250 µM DPG or 
SAG (DMSO as detergent). Incubation time was started with insulin (black 
bars) addition after ten min pre-incubation in the absence (basal) or in the 
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presence of vanadate (V) or plus 1 µM okadaic acid (V+OA) or 120 nM 
cyclosporine A (V+CsA) or 20 mM NaF (V+NaF). Results are calculated as 
percentages of incorporation values. Controls are set at 100 and the values are 
the mean ± S.D. of six individual samples. The significance level of V condition 
was calculated vis-à-vis the basal condition. The significance levels of V+OA, 
V+CsA and V+NaF conditions were calculated vis-à-vis the V condition.
*P < 0.050, **P < 0.005, ***P < 0.0001 vs. control.
#P < 0.050, ##P < 0.005, ###P < 0.0005 vs. insulin condition.
Fig. 6: Synaptosomal DAGK action on DPG or SAG as substrate as a 
function of time. Effect of GTPS and NaF in the absence and presence of 
insulin.  
DAGK activity was determined in CC synaptosomal membranes incubated 
during 5 min in the assay condition as described under “Experimental 
Procedures” by measuring radioactive phosphate incorporation into PA through 
[-32P]ATP as radioactive substrate in the presence of either 250 µM DPG or 
SAG (DMSO as detergent). Incubation time was started at zero time. Left 
panels: 200 nM insulin (dashed arrow) or 100 µM GTPS or 20 mM NaF (black 
arrow) were present from zero time incubation. Right panels: 100 µM GTPS 
or 20 mM NaF (black arrow) were added after five min pre-incubation in the 
presence of insulin (dashed arrow). In all insulin conditions 200 M vanadate 
was present. Results are expressed as the mean  S.D. of the incorporation 
values obtained in three individual samples.
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Fig. 7: Effect of GTPS and NaF on synaptosomal phosphatidylinositol 
bis-phosphate (PIP2) labeling with [-32P]ATP in the presence of 
exogenous DPG or SAG.  
PIP2 labeling was obtained measuring radioactive phosphate incorporation 
through [-32P]ATP as radioactive substrate in the presence of either 250 µM 
DPG or SAG (DMSO as detergent). GTPS (100 µM) and 20 mM NaF were 
present from zero time and during 5 min incubation.  Results are expressed as 
the mean  S.D. of the incorporation values obtained in six individual samples. 
The significance levels of the GTPS and NaF condition were calculated vis-à-
vis the respective control condition.
***P < 0.0001.
Fig. 8: Effect of insulin on synaptosomal PA and PIP+PIP2 labeling with
[-32P]ATP in the presence of exogenous DPG or SAG. Sodium fluoride 
action.  
PA, PIP and PIP2 labeling was obtained measuring radioactive phosphate 
incorporation through [-32P]ATP as radioactive substrate during 10 min in the 
presence of either 250 µM DPG or SAG (DMSO as detergent). Insulin was 
added after ten min pre-incubation in the presence of vanadate or vanadate 
plus sodium fluoride. Results are calculated as percentages of incorporation 
values with respect to control condition. The significance levels of the insulin 
condition were calculated vis-à-vis the control. The significance levels of the 
insulin+NaF condition were calculated vis-à-vis the insulin condition. 
*P < 0.050, **P < 0.0010, ***P < 0.0005 vs. control.  
##P < 0.0010, ###P < 0.0005 vs. I+V.
Table I: DAGK activity from CC synaptosomes measured with either DPG 
or SAG in a detergent-lipid micellar assay.    
DAGK activity was determined in CC synaptosomal membranes measuring 
radioactive phosphate incorporation into PA through [-32P]ATP as radioactive 
substrate and with either 1,2-dipalmitoyl-sn-glycerol (DPG) or 1-stearoyl-2-
arachidonoyl-sn-glycerol (SAG) in a detergent-micellar assay. The lipid was 
resuspended in 50 mM octyl-β-glucopyranoside (OG) at final concentrations of 
0.5 mol% in the assay condition as described under “Experimental 
Procedures”. Results are expressed as the mean ± S.D. of the incorporation
values obtained in three individual samples.
OG Assay (50 mM) DMSO Assay 
Conditions % SD % SD
Basal 100 8,88 100 3,05
DPG 341 38,74 209 35,71
SAG 1818 108,26 800 185,98
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Table II: Insulin effect on DAGK activity from CC or Hp synaptosomes 
measured with either DPG or SAG in a detergent-lipid micellar assay. 
DAGK activity was determined in synaptosomal membranes incubated during 5 
min in the assay condition as described under “Experimental Procedures”. 
Synaptosomes were obtained from cerebral cortex (CC) or hyppocampus (Hp) 
and DAGK activity was determined measuring radioactive phosphate 
incorporation into PA through [-32P]ATP as radioactive substrate and with 
either 1,2-dipalmitoyl-sn-glycerol (DPG) or 1-stearoyl-2-arachidonoyl-sn-
glycerol (SAG) in a detergent-micelar assay. The lipid was resuspended in 50 
mM octyl-β-glucopyranoside (OG) at final concentration of 250 M. Insulin (200 
nM) plus vanadate (200 µM), as insulin condition, were present from zero time. 
Results are expressed as the mean  S.D. of the incorporation values obtained 
in six individual samples. 
Tissue Lipid
Substrate
Control
(pmole PA/mg prot x min)
Insulin
(pmole PA/mg prot x min)
Hippocampus
Endog. DAG 0.737  0.018 2.202  0.134
SAG 14.123  0.708 38.893  2.366
DPG 3.377  0.394 8.865  1.133
Cerebral 
Cortex
Endog. DAG 0.743  0.066 1.467  0.196
SAG 13.506  0.710 22.228  2.494
DPG 2.531  0.445 6.300  0.509
Table II
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